Logo
x

Search

Subscribe Now

 breast cancer

Prestige Biopharma Reports the CHMP’s Positive Opinion of Tuznue (Biosimilar, Herceptin)

Prestige Biopharma Reports the CHMP’s Positive Opinion of Tuznue (Biosimilar, Herceptin)

  • July 29, 2024
New Drug Designations - May 2024

New Drug Designations - May 2024

  • June 25, 2024
The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Multiple Solid Tumors

The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Multiple Sol...

  • June 5, 2024
The US FDA Accepts and Grants Priority Review to Roche’s NDA of Inavolisib for Treating Breast Cancer

The US FDA Accepts and Grants Priority Review to Roche’s NDA of Inavolisib for Treating Breast Cancer

  • May 29, 2024
Roche’s Inavolisib Receives the US FDA’s Breakthrough Therapy Designation for Breast Cancer

Roche’s Inavolisib Receives the US FDA’s Breakthrough Therapy Designation for Breast Cancer

  • May 21, 2024
Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer

Biotheryx Receives the US FDA’s IND Approval of BTX-9341 for Treating Breast Cancer

  • May 8, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.